Activation of coagulation and fibrinolysis during cardiothoracic operations.

[1]  R. Colman,et al.  Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. , 1996, Circulation.

[2]  L. Mannucci,et al.  One Month Follow-up of Haemostatic Variables in Patients Undergoing Aortocoronary Bypass Surgery , 1995, Thrombosis and Haemostasis.

[3]  J. E. Doran,et al.  Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. , 1994, The Journal of thoracic and cardiovascular surgery.

[4]  H. Philippou,et al.  Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass , 1994, The Lancet.

[5]  H. Philippou,et al.  Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments] , 1993 .

[6]  H. Philippou,et al.  Thrombogenic mechanisms in the human: fresh insights obtained by immunodiagnostic studies of coagulation markers. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  P. Neuvonen,et al.  Anaesthesia affects plasma concentrations of vasopressin, von Willebrand factor and coagulation factor VIII in cardiac surgical patients. , 1993, British journal of anaesthesia.

[8]  H. Teufelsbauer,et al.  Early Activation of Hemostasis during Cardiopulmonary Bypass: Evidence for Thrombin Mediated Hyperfibrinolysis , 1992, Thrombosis and Haemostasis.

[9]  H. Teufelsbauer,et al.  Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. , 1991, The Journal of thoracic and cardiovascular surgery.

[10]  J. Jespersen,et al.  Enhanced Effective Fibrinolysis following the Neutralization of Heparin in Open Heart Surgery Increases the Risk of Post-Surgical Bleeding , 1990, Thrombosis and Haemostasis.

[11]  R. Demeyere.  Coagulation in cardiac surgery , 1990 .

[12]  I. Yada,et al.  Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. , 1989, Journal of cardiothoracic anesthesia.

[13]  R. Colman,et al.  Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass. , 1989, Blood.

[14]  C. Kluft,et al.  Enhanced fibrinolytic activity during cardiopulmonary bypass in open‐heart surgery in man is caused by extrinsic (tissue‐type) plasminogen activator , 1984, European journal of clinical investigation.

[15]  B. Bull,et al.  Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. , 1975, Anesthesiology.

[16]  R. Macfarlane.  FIBRINOLYSIS FOLLOWING OPERATION , 1937 .

[17]  R. P. Cochran,et al.  Individual Variations in the Fibrinolytic Response During and After Cardiopulmonary Bypass , 1995, Thrombosis and Haemostasis.

[18]  G. Dooijewaard,et al.  Protection of Single-chain Urokinase-type Plasminogen Activator (scu-PA) in Aprotinin Treated Cardiac Surgical Patients Undergoing Cardiopulmonary Bypass , 1995, Thrombosis and Haemostasis.

[19]  B. Risberg,et al.  Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  S. Y. Hong,et al.  Urokinase concentration in the renal artery and vein. , 1992, Nephron.

[21]  G. Fuhrer,et al.  Studies on components of the plasma kallikrein-kinin system in patients undergoing cardiopulmonary bypass. , 1986, Advances in experimental medicine and biology.

[22]  J. Loscalzo,et al.  Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. , 1985, Blood.